Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ACOG

Alpha Cognition Inc

Nov 20 • 04:00PM ET

5.78

Dollar change +0.12
Percentage change 2.12	%

Healthcare • Biotechnology • Canada • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.96	Insider Own	13.66%	Shs Outstand	6.03M	Perf Week	0.70%
Market Cap	124.25M	Forward P/E	-	EPS next Y	-	Insider Trans	0.52%	Shs Float	5.21M	Perf Month	-42.37%
Income	-14.77M	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-54.22%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-56.62%
Book/sh	-0.48	P/B	-	EPS next Y	-	ROA	-438.99%	Short Interest	-	Perf Year	-10.42%
Cash/sh	0.18	P/C	32.96	EPS next 5Y	-	ROE	-2248.79%	52W Range	5.35 - 18.50	Perf YTD	-53.47%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-5.95%	ROI	-	52W High	-68.75%	Beta	2.63
Dividend TTM	-	Quick Ratio	1.50	Sales past 5Y	0.00%	Gross Margin	-	52W Low	8.04%	ATR (14)	0.91
Dividend Ex-Date	-	Current Ratio	1.50	EPS Y/Y TTM	20.14%	Oper. Margin	0.00%	RSI (14)	35.89	Volatility	5.26% 10.13%
Employees	5	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	2.00	Target Price	36.13
Option/Short	No / Yes	LT Debt/Eq	-	EPS Q/Q	63.98%	Payout	-	Rel Volume	7.77	Prev Close	5.66
Sales Surprise	-	EPS Surprise	69.00%	Sales Q/Q	-	Earnings	Nov 15 AMC	Avg Volume	19.41K	Price	5.78
SMA20	-27.96%	SMA50	-37.79%	SMA200	-53.04%	Trades		Volume	134,825	Change	2.12%

Nov-15-24 05:00PM	Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update (Business Wire) -5.38% +6.15%
Nov-12-24 09:22AM	Alpha Cognition Announces Pricing of $50 Million Upsized Public Offering and Nasdaq Listing (Business Wire) -32.14%

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McFadden Michael E.	Chief Executive Officer	Nov 13 '24	Buy	5.75	2,608	14,996	14,142	Nov 15 04:23 PM
MERTZ LEONARD POWELL	Director	Nov 13 '24	Buy	5.75	8,695	49,996	93,725	Nov 15 04:19 PM
HAVENS JOHN PRENTISS	Director	Nov 13 '24	Buy	5.75	4,347	24,995	273,272	Nov 15 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACOG

Alpha Cognition Inc

Upgrade your FINVIZ experience